Described herein are nanoparticle drug conjugates (NDCs), which, in certain embodiments, comprise a non-toxic, multi-modality, clinically proven silica-based nanoparticle platform with covalently attached drug molecules/moieties. The nanoparticle drug conjugates (NDCs) demonstrate imaging capability and targeting ligands which efficiently clear through the kidneys. Furthermore, the conjugates incorporate therapeutic agents for cancer detection, prevention, and/or treatment.
                            本文描述的是纳米颗粒药物共轭物(NDCs),在某些实施方案中,它包括无毒、多模态、经临床验证的
硅基纳米颗粒平台与共价连接的药物分子/分子。纳米颗粒药物共轭物(NDCs)具有成像能力和靶向
配体,能有效地通过肾脏清除。此外,这些共轭物还含有用于癌症检测、预防和/或治疗的治疗剂。